Return on average equity - 5 year average | 19.69 |
Net Income/employee - trailing 12 month | 4,02,962.80 |
Revenue/employee - most recent fiscal year | 19,23,665.00 |
Return on investment - most recent fiscal year | 18.91 |
Return on average assets - most recent fiscal year | 16.93 |
Receivables turnover - most recent fiscal year | 6.36 |
Return on investment - trailing 12 month | 20.35 |
Return on average assets - trailing 12 month | 18.29 |
Inventory turnover - most recent fiscal year | 3.73 |
Inventory turnover - trailing 12 month | 3.24 |
Revenue/employee - trailing 12 month | 19,71,455.00 |
Return on average assets - 5 year average | 16.19 |
Net Income/employee - most recent fiscal year | 3,51,995.90 |
Return on average equity - trailing 12 month | 21.03 |
Receivables turnover - trailing 12 month | 9.83 |
Asset turnover - most recent fiscal year | 0.93 |
Asset turnover - trailing 12 month | 0.89 |
Return on average equity - most recent fiscal year | 19.43 |
Return on investment - 5 year average | 18.97 |
Jenburkt Pharmaceuticals Dividend Jenburkt Pharmaceuticals Bonus Jenburkt Pharmaceuticals News Jenburkt Pharmaceuticals AGM Jenburkt Pharmaceuticals Rights Jenburkt Pharmaceuticals Splits Jenburkt Pharmaceuticals Board Meetings Jenburkt Pharmaceuticals Shareholdings Jenburkt Pharmaceuticals Profit Loss Jenburkt Pharmaceuticals Balance Sheet Jenburkt Pharmaceuticals Cashflow Jenburkt Pharmaceuticals Q1 Results Jenburkt Pharmaceuticals Q2 Results Jenburkt Pharmaceuticals Q3 Results Jenburkt Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks